CD4 Count | Coefficient (95% CI) | P |
---|---|---|
Time (Reference = 0–6 months) | ||
 6–12 months | 28.97 (1.48, 2.89) | <.01 |
 12–18 months | 46.8 (1.49, 3.29) | <.01 |
 18–24 months | 63.21 (1.73, 3.91) | <.01 |
 24–30 months | 69.54 (1.93, 4.63) | <.01 |
 30–36 months | 93.68 (2.01, 5.42) | <.01 |
Gender (Reference = Male) | 14.3 (0.27, 1.02) | 0.76 |
Race/Ethnicity (Reference = White) | ||
 Asian | −1.22 (0.45, 2.06) | <.01 |
 Black | −62.62 (0.21, 0.58) | 0.05 |
 Hispanic | −79.72 (0.29, 0.85) | <.01 |
 Other | 48.12 (0.08, 1.56) | 0.62 |
Age (at enrollment) | −2.13 (1.00, 1.04) | 0.03 |
Deductible level (Reference = none)a | ||
 Low deductible | −14.62 (0.36, 1.11) | 0.33 |
 High deductible | 13.36 (0.42, 1.00) | 0.36 |
Exchange (Reference = not through exchange)b | 15.28 (0.54, 1.42) | 0.27 |
AIDS Drug Assistance Program (Reference = none) | 27.37 (1.32, 3.66) | 0.26 |
HIV RNA level < 75 Copies/mL | OR (95% CI) | P |
Time (Reference = 0–6 months) | ||
 6–12 months | 2.06 (1.48, 2.89) | <.01 |
 12–18 months | 2.22 (1.49, 3.29) | <.01 |
 18–24 months | 2.6 (1.73, 3.91) | <.01 |
 24–30 months | 2.99 (1.93, 4.63) | <.01 |
 30–36 months | 3.3 (2.01, 5.42) | <.01 |
Gender (Reference = Male) | 0.52 (0.27, 1.02) | 0.06 |
Race/Ethnicity (Reference = White) | ||
 Asian | 0.97 (0.45, 2.06) | 0.93 |
 Black | 0.35 (0.21, 0.58) | <.01 |
 Hispanic | 0.5 (0.29, 0.85) | 0.01 |
 Other | 0.36 (0.08, 1.56) | 0.17 |
Age (at enrollment) | 1.02 (1.00, 1.04) | 0.04 |
Deductible level (Reference = none)a | ||
 Low deductible | 0.63 (0.36, 1.11) | 0.11 |
 High deductible | 0.65 (0.42, 1.00) | 0.05 |
Exchange (Reference = not through exchange)b | 0.88 (0.54, 1.42) | 0.59 |
AIDS Drug Assistance Program (Reference = none) | 2.2 (1.32, 3.66) | 0.01 |